Besides its relevance in FA, accumulating evidence indicates that UBE2T also plays an oncogenic role in various cancer, including hepatocellular carcinoma [10], gastric cancer [11], breast cancer [12], multiple myeloma [13], osteosarcoma [14], and NSCLC [15]. This evidence concerns the gene UBE2T and plasma cell myeloma.